Condition guide

Scleral lenses for ocular graft-versus-host disease

After a stem-cell or bone-marrow transplant, the eyes are often caught up in chronic GVHD. Here is how a fluid-filled scleral lens can help, what the research shows, and its limits.

By the Scleral Lens Team · Updated October 5, 2026 · 12 published sources cited

Scroll to see how a scleral lens helps

  1. 01 Your eye

    From the front you see the clear cornea, the colored iris, and the pupil. To see how light travels through it, we cut it in half.

  2. 02 A healthy tear film

    A smooth layer of tears coats the cornea. Every blink spreads a fresh, even film, and light passes through it cleanly.

  3. 03 What this eye sees

    With a healthy cornea, a sunny afternoon is crisp: clean edges, clear light, full color.

  4. 04 Ocular GVHD

    After a stem-cell or bone-marrow transplant, donor immune cells can attack the tear glands and the surface of the eye. Tears dry up, the surface is damaged, and vision blurs and stings.

  5. 05 The lens lands

    A scleral lens rests on the white of the eye and arches over the cornea without touching it. The blinking lid now glides over the lens, not the cornea.

  6. 06 Saline fills the gap

    The lens is filled with saline before it goes in. That fluid bathes the cornea all day, so it never dries out between blinks.

  7. 07 Steady and clear

    With the cornea bathed and shielded, vision steadies and the surface can heal. Your eye doctor and transplant team keep treating the GVHD itself.

Illustration, not to scale. Simulated vision varies from person to person.

What it is

After an allogeneic stem-cell or bone-marrow transplant, donor immune cells can attack the tear glands, eyelids, and eye surface. The result is often severe, painful dry eye.

How scleral lenses help

The lens rests on the white of the eye and holds a pool of sterile saline over the cornea. That keeps the surface wet all day and shields it from the rubbing of the eyelids.

Where they fall short

They protect and soothe the eye but don't treat GVHD itself. Handling can be hard when someone is unwell, and not everyone keeps wearing them.

57%
Of patients with chronic GVHD had ocular GVHD within 2 years of diagnosis in a multicenter study[2]
293 days
Median time from transplant to the onset of chronic ocular GVHD in 200 patients[4]
71 of 79
Eyes with ocular chronic GVHD that saw better with PROSE scleral devices[8]
20/40 to 20/25
Median vision with glasses vs with mini-scleral lenses in 62 eyes with ocular GVHD[9]
22.6%
Of patients in that same study stopped wearing mini-scleral lenses[9]
63%
Of surveyed oGVHD patients not wearing scleral lenses said they had never heard of them[11]

How ocular GVHD affects the eye and vision

Graft-versus-host disease (GVHD) can follow an allogeneic stem-cell or bone-marrow transplant, where the new blood-forming cells come from a donor. The donor’s immune cells can attack the recipient’s own tissues. Chronic GVHD is a slower, longer-lasting form. One major review reports that it affects up to 70% of transplant patients.[1]

The eyes are one of the organs most often involved. In a multicenter study of 284 people with chronic GVHD, 41% already had eye involvement within three months of their chronic GVHD diagnosis, and 57% had it within two years.[2] In a Dutch study that followed 101 transplant patients, ocular GVHD developed over time in 54%.[3]

The main problem is severe dry eye. The immune attack damages the tear glands, the oil glands along the eyelid margins, and the conjunctiva (the thin membrane over the white of the eye). Keratoconjunctivitis sicca, the medical term for this dryness, occurs in 40% to 90% of patients with ocular chronic GVHD.[7] People describe gritty, burning, painful eyes, sensitivity to light, and blurry vision that comes and goes with blinking. In more severe cases the conjunctiva scars and the cornea (the clear front window of the eye) breaks down.

Eye symptoms can start well after the transplant. In a review of 200 patients, the median time to onset of chronic ocular GVHD was 293 days after transplant. Eye involvement followed GVHD elsewhere in the body in 76% of patients, but came first in 7%.[4] That is one reason many experts encourage eye exams after transplant even when the rest of the body is doing well.

How it’s diagnosed. The NIH consensus criteria for chronic GVHD list new dry, gritty, or painful eyes, scarring of the conjunctiva, keratoconjunctivitis sicca, and patches of damage on the corneal surface as distinctive eye signs. A Schirmer tear test of 5 mm or less at 5 minutes, or new dry-eye damage seen on a slit-lamp exam with a Schirmer value of 6 to 10 mm, is enough to diagnose ocular chronic GVHD for treatment, provided nothing else explains it.[5] A separate international group of eye specialists proposed a scoring system built on four measures: a symptom questionnaire, the Schirmer test, corneal staining, and redness of the conjunctiva. It sorts patients into no, probable, or definite ocular GVHD.[6]

How a scleral lens works for ocular GVHD

A scleral lens is a large rigid gas-permeable lens. It rests on the sclera (the white of the eye) and arches over the whole cornea without touching it. Before insertion the lens is filled with sterile, preservative-free saline, so a pool of fluid sits against the cornea for as long as the lens is in.

That arrangement helps a GVHD eye in two ways:

  • It keeps the cornea bathed. When the eye can’t make enough tears, the saline reservoir does the job of a tear film. The cornea stays wet between blinks and throughout the day, not just for the minutes after an eye drop.
  • It shields the cornea from the eyelids. Inflamed lid margins and a dry surface make every blink rub. With a scleral lens in place, the lids glide over the smooth lens instead of the damaged cornea. That can let surface damage heal.

The fluid layer also smooths out an irregular corneal surface optically, which is why vision often sharpens as well as comfort improving.

PROSE (prosthetic replacement of the ocular surface ecosystem) is a scleral-device treatment developed by the Boston Foundation for Sight. Much of the early research in ocular GVHD used PROSE devices. More recent studies use other custom and mini-scleral lens designs.

Working with your transplant team. Ocular GVHD is one part of a disease that can affect the skin, mouth, lungs, and other organs. Many patients take medicines that suppress the immune system. A scleral lens fitter should be in contact with the eye doctor managing the GVHD and aware of the transplant team’s plan, so that lens wear, eye drops, and any changes in systemic treatment fit together.

What the research shows

Vision and comfort improve for most people who are fitted. In a study of 79 eyes with ocular chronic GVHD, 71 eyes (90%) saw better with PROSE. On average, vision improved from about 20/60 to about 20/30. Corneal staining, a sign of surface damage, decreased in 84% of eyes. Among patients with follow-up questionnaires, the Ocular Surface Disease Index (a symptom score, where higher is worse) fell from 72.6 to 21.1.[8]

Newer mini-scleral lenses show similar results. A 2024 study of 62 eyes found median vision of 20/25 with mini-scleral lenses, compared with 20/40 in glasses. The median symptom score fell from 73 to 27, and corneal staining improved.[9]

The benefit shows up in everyday function. A review of PROSE treatment records found 407 patients with ocular chronic GVHD treated between 2002 and 2011. Among patients treated at network clinics in 2010, scores on a standard visual-function questionnaire rose by 41 points six months after treatment.[7] An earlier series fitted all 10 eyes of 5 patients with severe dry eye from GVHD. All 5 reported better comfort, and vision improved in 7 of the 10 eyes.[10]

Patients report broad relief, and many find out late. In a survey of 306 people with ocular GVHD, scleral lens wearers most often reported less dryness and grittiness (94%) and less eye pain (92%). Of the wearers, 56% wished the lenses had been recommended sooner. Among those not wearing scleral lenses, the most common reason was that they had never heard of them (63%).[11]

Other options, compared

Scleral lenses usually sit alongside other treatments rather than replacing them. Your eye doctor and transplant team decide the mix.

Option What it does Typically suited to
Preservative-free artificial tears, gels, and ointments Add moisture to the eye surface Everyone with ocular GVHD, as a base layer
Warm compresses and lid care Help the oil glands along the lid margins Lid-margin inflammation and blocked glands
Punctal plugs or punctal closure Keep the eye’s own tears on the surface longer Moderate to severe dryness
Prescription anti-inflammatory drops Calm inflammation on the eye surface Active inflammation; chosen and monitored by an eye doctor
Autologous serum or other blood-derived drops Drops made from the patient’s own blood Severe dryness or surface damage not controlled by other drops
Bandage soft contact lenses Cover the cornea to help it heal Short-term use for surface breakdown
Scleral lenses Hold a saline reservoir over the cornea and shield it from the lids Moderate to severe cases when drops and plugs aren’t enough
Surgery to the lids or ocular surface Repair scarring, protect the cornea, or partly close the lids Severe scarring or corneal breakdown

Questions to ask a scleral lens fitter

  • How many patients with ocular GVHD do you fit each year?
  • Will you share your notes with my eye doctor and my transplant team?
  • Which lens design do you use, and how many visits does a fit usually take?
  • What cleaning routine do you recommend while I’m on immune-suppressing medicine?
  • Can a family member or caregiver learn to put the lenses in and take them out?
  • What should I do if a lens fogs, or if my eye becomes red or painful while wearing it?
  • Do you bill my insurance directly, or give me a superbill to submit myself?

Common questions

Can scleral lenses cure ocular GVHD?

No. GVHD is an immune reaction, and a lens doesn't change it. A scleral lens protects the eye surface and keeps it wet, which can ease pain and improve vision. Treatment of the GVHD itself stays with your transplant team and eye doctor.

When should I think about scleral lenses?

They are usually considered when drops, ointments, plugs, and prescription anti-inflammatory drops aren't enough. In a survey of people with ocular GVHD, 56% of scleral lens wearers wished the lenses had been recommended sooner. Ask your eye doctor whether you are a candidate.

Is it safe to wear scleral lenses while on immune-suppressing medicine?

Many people with GVHD do wear them, but it needs care. Your fitter and your transplant team should both know about the lenses, and you should follow cleaning and follow-up instructions closely. Remove the lens and call your eye doctor the same day if your eye becomes red, painful, or your vision drops.

What if I'm too unwell or weak to handle the lenses?

Handling is a real barrier. Some people have a family member or caregiver learn to insert and remove the lenses. In one study, 22.6% of patients stopped wearing mini-scleral lenses, so it is worth talking through practical help before starting.

Are scleral lenses covered by insurance for GVHD?

Sometimes. Some medical plans cover scleral lenses when they are medically necessary for a disease of the eye surface. Coverage depends on your plan and on whether the practice is in network, so ask for the codes and a written estimate.

Will I still need serum tears or my other eye drops?

Often, yes, though many wearers say they need them less once the lenses are in. Drops and gels are still commonly used when the lenses are out, especially at night. Don't stop or cut back any prescribed eye medicine without your eye doctor's advice.

My eyes still flare up even though the lenses fit well. Is that expected?

Ocular GVHD can flare with illness, allergies, and other triggers, with or without lenses. Tell your eye doctor and fitter about flares, since your treatment or lens routine may need adjusting. If your eye becomes red and painful or your vision drops, remove the lens and call your eye doctor today.

My new lenses aren't as comfortable or clear as I hoped. What should I do?

Go back to your fitter, because the first lens is rarely the final one. Fits are often refined over several visits, and early discomfort sometimes improves as the eye surface settles. Write down what bothers you and when, so your fitter can target the problem.

Can I have cataract surgery if I wear scleral lenses for GVHD?

Yes, wearers with ocular GVHD have had cataract surgery. Your surgeon, fitter, and transplant team should plan it together, including how your dry eye is managed around the operation. Expect a new lens prescription and possibly a refit once the eye has healed.

Related conditions

Sources

  1. Soleimani M, Mahdavi Sharif P, Cheraqpour K, et al. Ocular graft-versus-host disease (oGVHD): from A to Z. Surv Ophthalmol. 2023;68(4):697-712. pubmed.ncbi.nlm.nih.gov
  2. Sun YC, Chai X, Inamoto Y, et al. Impact of ocular chronic graft-versus-host disease on quality of life. Biol Blood Marrow Transplant. 2015;21(9):1687-1691. pubmed.ncbi.nlm.nih.gov
  3. Westeneng AC, Hettinga Y, Lokhorst H, Verdonck L, van Dorp S, Rothova A. Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea. 2010;29(7):758-763. pubmed.ncbi.nlm.nih.gov
  4. Shikari H, Amparo F, Saboo U, Dana R. Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation. Cornea. 2015;34(3):243-247. pubmed.ncbi.nlm.nih.gov
  5. Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015;21(3):389-401.e1. pubmed.ncbi.nlm.nih.gov
  6. Ogawa Y, Kim SK, Dana R, et al. International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep. 2013;3:3419. pubmed.ncbi.nlm.nih.gov
  7. DeLoss KS, Le HG, Gire A, Chiu GB, Jacobs DS, Carrasquillo KG. PROSE treatment for ocular chronic graft-versus-host disease as a clinical network expands. Eye Contact Lens. 2016;42(4):262-266. pubmed.ncbi.nlm.nih.gov
  8. Theophanous C, Irvine JA, Parker P, Chiu GB. Use of prosthetic replacement of the ocular surface ecosystem scleral lenses in patients with ocular chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21(12):2180-2184. pubmed.ncbi.nlm.nih.gov
  9. Keye P, Issleib S, Gier Y, et al. Visual and ocular surface benefits of mini-scleral contact lenses in patients with chronic ocular graft-versus-host disease (GvHD). Sci Rep. 2024;14(1):25254. pubmed.ncbi.nlm.nih.gov
  10. Schornack MM, Baratz KH, Patel SV, Maguire LJ. Jupiter scleral lenses in the management of chronic graft versus host disease. Eye Contact Lens. 2008;34(6):302-305. pubmed.ncbi.nlm.nih.gov
  11. Bligdon SM, Colarusso BA, Ganjei AY, Kwok A, Luo ZK, Brocks D. Scleral lens and prosthetic replacement of the ocular surface ecosystem utilization in ocular graft-versus-host disease: a survey study. Clin Ophthalmol. 2021;15:4829-4838. pubmed.ncbi.nlm.nih.gov
  12. Schear MJ, Ibrahim K, Winokur J, Busuioc C, Udell I, Steiner A. Treatment limitations with PROSE (prosthetic replacement of the ocular surface ecosystem): one center's experience. Eye Contact Lens. 2019;45(5):315-317. pubmed.ncbi.nlm.nih.gov

Last updated October 5, 2026. Found an error or a newer study? Let us know and we'll correct the page.